(Q77653625)
Statements
The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin's lymphoma (English)
M Moos
R Schulz
S Martin
A Benner
1 December 1998